Leslie Robbins

Leslie Robbins joined CytomX in February 2019 as senior vice president of intellectual property. Ms. Robbins brings more than 25 years of legal experience in the biotechnology industry to CytomX. Most recently, Ms. Robbins was vice president of intellectual property at Coherus BioSciences, a biosimilars company. Prior to that, she held intellectual property roles at Onyx Pharmaceuticals (acquired by Amgen) and Elan Pharmaceuticals. Ms. Robbins began her legal career at a boutique patent firm. Prior to law school, Ms. Robbins was a research associate at Chiron Corporation.

Ms. Robbins received a J.D. from the Chicago-Kent College of Law at the Illinois Institute of Technology and a bachelor’s degree in microbiology and immunology from the University of California, Berkeley.